Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass (OAGB-vs-LRYGB)

April 18, 2020 updated by: Miguel J. Garcia-Oria, Puerta de Hierro University Hospital

Prospective Randomized Controlled Clinical Trial: Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass

This study try to identify differences in cost, length of operation and results between two different bariatric surgical techniques, the laparoscopic Roux-en-Y gastric bypass and the Single anastomosis laparoscopic gastric bypass. The study will be conducted in a Spanish public health system hospital.

The patients of the trial will have the preoperative studies, hospital treatment during the admission, postoperative treatment and follow up as any other patient included in the hospital bariatric surgery program. No new methods are applied other than randomly choose the surgical technique.

Patients will be randomized in a 1:1 ratio to each group.

Study Overview

Detailed Description

One group of patients of the study will have done the simplified laparoscopic gastric bypass, with a vertical gastric pouch of about 20 ml, a 150 cm Roux-en-Y limb constructed in an antegastric antecolic fashion, and a biliary limb of 100 cm. Anastomosis will be done with endoscopic surgical linear stapler, closing the apertures with continuous absorbable running sutures. The Petersen space and the mesenteric defect will be closed with non-absorbable sutures.

The other group of patients will have performed the single anastomosis gastric bypass, also known as the Minigastric bypass (MGB), which have a vertical gastric pouch about 100-150 ml, and an end to side gastro-jejunal anastomosis at 200 cm from Treitz angle. The anastomosis will be done with endoscopic surgical linear stapler, closing the aperture with continuous absorbable running sutures.The Petersen space will be also close with non-absorbable sutures.

The investigators randomly assigned 10 patients to each group, n=20. Considering that one of the methods is basically the same than the other, but for the Roux-en-Y construction, it is expected a clear difference in operating room (OR) time, between groups. Fisher Test, will be used for the statistical analysis, assuming a risk of 0.05 and a statistical power of 90%, and Mann-Whitney test for quantitative parameters.

Once patients were included in the study, they were randomized in a 1:1 ratio to the conventional laparoscopic gastric bypass group or the single-anastomosis laparoscopic gastric bypass (Mini gastric bypass) group and were also blinded to the surgeon until surgery. The method of randomization was concealed envelopes.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Majadahonda, Madrid, Spain, 28222
        • Servicio de Cirugía General. Hospital Universitario Puerta de Hierro Majadahonda

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • criteria for bariatric surgery published in 1991 for the National Institutes of Health of the USA.
  • age between 18-65 years-old.
  • BMI between 40-50 kg/m2
  • Obesity for more than 5 years of evolution
  • Fail in medical supervised weight loss program
  • patient knowing of the mechanism of weight loss after surgery and agreement to collaborate with medical recommendations, diet, medical treatment, as well as the visit established in the follow up program
  • patient accepting that surgery objective is not to achieve the ideal weight.
  • signed specific informed consent
  • women will agree in avoid gestation during one year after surgery

Exclusion Criteria:

  • Patients unable to sign the informed consent form because of a mental disorder.
  • endocrine diseases causing obesity
  • unstable mental disorder, evaluated for a psychiatry MD.
  • high anesthetic risk making surgery too risky.
  • Malignant neoplasm
  • Gastroesophageal reflux disease (GERD) with endoscopic esophagitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Minigastric bypass
Intervention(s): The patient will have done a Laparoscopic one anastomosis gastric bypass (minigastric bypass) at the time of the surgical procedure.
The patient will be submitted to a minigastric bypass at the time of the operation
Other Names:
  • Single or One anastomosis gastric bypass
Active Comparator: Gastric bypass
The patient will have a Laparoscopic Roux-en-Y gastric bypass at the time of the surgical procedure
In this case a simplified conventional gastric bypass will be performed
Other Names:
  • Laparoscopic gastric bypass

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Cost in euros
Time Frame: up to 3 months
Total hospital expenses during admission for the surgery
up to 3 months
Length of operation in minutes
Time Frame: 1 day
Duration of the surgical procedure
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight loss in kilograms
Time Frame: 3 months
weight of the patient at clinics, 3 months after surgery
3 months
weight loss in kilograms
Time Frame: 6 months
weight of the patient at clinics, 6 months after surgery
6 months
weight loss in kilograms
Time Frame: 9 months
weight of the patient at clinics, 9 months after surgery
9 months
weight loss in kilograms
Time Frame: 12 months
weight of the patient at clinics, 12 months after surgery
12 months
weight loss in kilograms
Time Frame: 18 months
weight of the patient at clinics, 18 months after surgery
18 months
weight loss in kilograms
Time Frame: 24 months
weight of the patient at clinics, 24 months after surgery
24 months
weight loss in kilograms
Time Frame: 3 years
weight of the patient at clinics, 3 years after surgery
3 years
weight loss in kilograms
Time Frame: 4 years
weight of the patient at clinics, 4 years after surgery
4 years
weight loss in kilograms
Time Frame: 5 years
weight of the patient at clinics, 5 years after surgery
5 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment
Time Frame: through study completion an average of 5 year
Record of any adverse event and/or abnormal laboratory values in relation with the operation performed since the day of the operation to the study completion.
through study completion an average of 5 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Miguel J Garcia-Oria, MD PhD FACS, Unidad Cirugia Obesidad y Metabolica Hospital Puerta de Hierro

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Actual)

November 1, 2019

Study Completion (Anticipated)

June 1, 2025

Study Registration Dates

First Submitted

May 16, 2016

First Submitted That Met QC Criteria

May 19, 2016

First Posted (Estimate)

May 20, 2016

Study Record Updates

Last Update Posted (Actual)

April 21, 2020

Last Update Submitted That Met QC Criteria

April 18, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The plan is to publish the results of our study in a scientific journal when it be completed, not to publish the individual patient data, just the global data comparing both groups of study.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Minigastric bypass

3
Subscribe